Quarterly ResultMay 6, 2026, 04:21 PM
Guardian Pharmacy Services Q1 Revenue $336.6M; Raises FY Adjusted EBITDA Guidance
AI Summary
Guardian Pharmacy Services reported strong first-quarter 2026 financial results, with revenue increasing 2% to $336.6 million and net income rising to $13.5 million from $9.3 million year-over-year. The company successfully navigated the impact of the Inflation Reduction Act, maintaining margin stability and achieving double-digit Adjusted EBITDA growth to $29.8 million. Concurrently, Guardian Pharmacy Services updated its full-year 2026 Adjusted EBITDA guidance upwards to $123 million - $127 million, citing discrete benefits and favorable payor dynamics.
Key Highlights
- Q1 2026 Revenue increased 2% year-over-year to $336.6 million.
- Q1 2026 Net Income rose to $13.5 million, up from $9.3 million in the prior-year period.
- Q1 2026 Adjusted EBITDA grew 27.4% to $29.8 million.
- Residents served increased 10% year-over-year to approximately 207,000.
- Diluted EPS was $0.21, with Adjusted EPS at $0.29.
- Full-year 2026 Adjusted EBITDA guidance raised to $123 million - $127 million.
- Completed a non-dilutive secondary offering of 6.9 million shares in March 2026.
- Ended Q1 with $64.9 million in cash and no long-term debt outstanding.